Clinical trial

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable…

NCT00306163 · AstraZeneca, Industry · Completed

Key facts

NCT number NCT00306163
Title Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
Official title Nebulizer Trial: Evaluation of the Influence of Particle Size of Aerosolized AMP on Bronchial Responsiveness in Patients With Asthma and the Effects of Treatment With Ciclesonide Versus Fluticasone.
Lead sponsor AstraZeneca, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions Ciclesonide, Fluticasone
Enrollment 37
Start date May 1, 2006
Primary completion Aug 1, 2008
Completion Sep 1, 2008
First posted Mar 23, 2006
Last update posted Feb 1, 2017
Countries Netherlands

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies